Related Experiment Video

Updated: Feb 15, 2026

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.5K

Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Chi Young Jung1, Scott J Antonia2

  • 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.

Tuberculosis and Respiratory Diseases
|January 15, 2018
PubMed

Insights

New treatments are needed for advanced non-small cell lung cancer (NSCLC). Cancer immunotherapy, particularly immune checkpoint inhibitors, shows promise for improving long-term survival in NSCLC patients.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Lung cancer is a leading cause of cancer deaths globally.
  • Current 5-year survival rates for advanced non-small cell lung cancer (NSCLC) remain low (10%-20%).
  • There is a critical need for novel therapeutic strategies for advanced NSCLC.

Purpose of the Study:

  • To review the fundamentals of tumor immunology.
  • To summarize clinical data on immunotherapeutic approaches for NSCLC.
  • To highlight the role of immune checkpoint inhibitors in NSCLC treatment.

Main Methods:

  • Literature review of basic tumor immunology.
  • Analysis of clinical trial data for immunotherapies in NSCLC.
  • Focus on immune checkpoint inhibitors as a therapeutic strategy.

Main Results:

  • Cancer immunotherapy utilizes the patient's immune system to combat cancer.
  • Immunotherapy offers potential for long-term remission and fewer side effects than traditional treatments.
  • Immune checkpoint inhibitors are a key advancement and standard of care for advanced NSCLC.

Conclusions:

  • Immuno-oncology is a rapidly developing field for NSCLC treatment.
  • Immune checkpoint inhibitors represent a significant breakthrough in NSCLC immunotherapy.
  • Further research and clinical application of immunotherapy are crucial for improving patient outcomes.
Keywords:
Carcinoma, Non-Small-Cell LungCell Cycle CheckpointsImmunotherapy

More Related Videos

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.6K
Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

23.5K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.9K
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.1K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
What is the Immune System?01:38

What is the Immune System?

Overview
133.3K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.5K